Alx Oncology Holdings (ALXO) Current Assets (2019 - 2026)

Alx Oncology Holdings (ALXO) has 8 years of Current Assets data on file, last reported at $145.6 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 41.97% year-over-year to $145.6 million; the trailing twelve-month figure through Mar 2026 stood at $145.6 million (up 41.97% YoY), and the FY2025 full-year result was $50.7 million, down 62.24% from the prior year.
• Current Assets climbed to $145.6 million in Q1 2026, from $50.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $321.5 million in Q1 2022 to a low of $50.7 million in Q4 2025.
• A 5-year average of $183.4 million and a median of $168.7 million in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets sank 62.24% in 2025 and jumped 41.97% in 2026, its largest moves.
• Tracing ALXO's Current Assets over 5 years: stood at $271.0 million in 2022, then tumbled by 30.38% to $188.7 million in 2023, then slipped by 28.79% to $134.4 million in 2024, then slumped by 62.24% to $50.7 million in 2025, then surged by 186.96% to $145.6 million in 2026.
• Business Quant data shows ALXO's Current Assets at $145.6 million in Q1 2026, $50.7 million in Q4 2025, and $66.5 million in Q3 2025.